Document is current

Any future updates will be listed below

Correction to: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation

Crossref DOI link: https://doi.org/10.1186/s13046-022-02324-2

Published Online: 2022-04-11

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark